CLINICAL_TRIALS
trial_result
· 2013-05-20
Clinical Trial Update: Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet
Summary
The document notes the completion of a clinical trial evaluating AMERGE (naratriptan hydrochloride) tablets for migraine disorders, sponsored by GlaxoSmithKline…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Status: COMPLETED